Kenfak-Foguena Alain, Nahimana Tessemo Immaculée, Bertelli Claire, Merz Laurent, Cometta Alain, Blanc Dominique, Senn Laurence, Petignat Christiane
Service of Internal Medicine, Jura Bernois Hospital, Moutier, Switzerland.
Cantonal Unit for Infection Control and Prevention, Public Health Service, Lausanne, Switzerland.
J Infect Prev. 2021 Jul;22(4):173-176. doi: 10.1177/1757177420982033. Epub 2021 Jan 12.
The recent increase of migration to Europe represents a risk of increased the prevalence of multidrug-resistant (MDR) bacteria. We conducted a cross-sectional study among asylum seekers admitted at two hospitals in Switzerland. Of the 59 patients included, 9 (14%) were colonised by a MDR bacteria, including 5 (8.5%) methicilin-resistant (MRSA) and 4 (6.8%) extended-spectrum beta-lactamase (ESBL)-producing . No patient carried both ESBL-producing bacteria and MRSA. None of the patients carried a vancomycin-resistant (VRE) or a carbapenem-resistant (CRE). Colonisation with MDR bacteria was not associated with hospitalisation abroad or recent arrival in Switzerland. Whole genome sequencing analysis allowed us to exclude transmission between patients. The prevalence of MDR bacteria carriage is moderate among asylum seekers in western Switzerland. Further surveillance studies are necessary to determine if there is a risk of dissemination of pathogens into the local population.
近期向欧洲移民人数的增加意味着耐多药(MDR)细菌流行率上升的风险。我们在瑞士两家医院收治的寻求庇护者中开展了一项横断面研究。纳入的59例患者中,9例(14%)被MDR细菌定植,其中5例(8.5%)为耐甲氧西林金黄色葡萄球菌(MRSA),4例(6.8%)产超广谱β-内酰胺酶(ESBL)。没有患者同时携带产ESBL细菌和MRSA。没有患者携带耐万古霉素肠球菌(VRE)或耐碳青霉烯类肠杆菌(CRE)。MDR细菌定植与国外住院史或近期抵达瑞士无关。全基因组测序分析使我们能够排除患者之间的传播。瑞士西部寻求庇护者中MDR细菌携带率处于中等水平。有必要开展进一步的监测研究,以确定病原体传播至当地人群的风险。